HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rachel Thijssen Selected Research

Lymphadenopathy

1/2016Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rachel Thijssen Research Topics

Disease

8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2022 - 08/2015
5Neoplasms (Cancer)
11/2020 - 01/2019
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 01/2019
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 11/2020
2Disease Progression
01/2021 - 01/2019
1Leukemia
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Lymphoma (Lymphomas)
01/2020
1Lymphadenopathy
01/2016
1Lymphocytosis
01/2016

Drug/Important Bio-Agent (IBA)

11venetoclaxIBA
11/2022 - 08/2015
4Proteins (Proteins, Gene)FDA Link
11/2022 - 10/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2016
2Pharmaceutical PreparationsIBA
01/2021 - 01/2020
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2022
1navitoclaxIBA
01/2021
1ibrutinibIBA
01/2019
1Circulating Tumor DNAIBA
01/2019
11- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA
01/2016
1AntibodiesIBA
08/2015
1Phosphotransferases (Kinase)IBA
08/2015

Therapy/Procedure

5Therapeutics
11/2022 - 01/2019